Financial Ratios

GODAVARI DRUGS LTD.

NSE : NABSE : 530317ISIN CODE : INE362C01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE92.950.75 (+0.81 %)
PREV CLOSE ( ) 92.20
OPEN PRICE ( ) 94.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14169
TODAY'S LOW / HIGH ( )91.40 94.05
52 WK LOW / HIGH ( ) 73.31114
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)5.036.975.482.661.60
   CEPS(Rs)7.619.227.114.203.05
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)44.3839.3532.3826.9024.24
   Tax Rate(%)23.2825.2927.6612.5930.78
Margin Ratios
   Core EBITDA Margin(%)6.227.018.026.316.57
   EBIT Margin(%)5.556.137.365.445.56
   Pre Tax Margin(%)3.094.364.652.392.09
   PAT Margin (%)2.373.263.372.091.45
   Cash Profit Margin (%)3.594.314.363.312.75
Performance Ratios
   ROA(%)3.405.454.722.541.77
   ROE(%)12.0119.4218.4910.396.85
   ROCE(%)14.5318.3517.5811.8012.14
   Asset Turnover(x)1.431.671.401.211.22
   Sales/Fixed Asset(x)3.333.443.132.802.50
   Working Capital/Sales(x)12.009.727.179.998.13
Efficiency Ratios
   Fixed Capital/Sales(x)0.300.290.320.360.40
   Receivable days129.78114.07120.71133.44132.67
   Inventory Days34.1727.9648.2165.2665.40
   Payable days127.50101.87112.95144.33150.09
Valuation Parameters
   PER(x)15.079.398.354.3514.55
   PCE(x)9.967.096.442.757.66
   Price/Book(x)1.711.661.410.430.96
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.560.430.520.360.46
   EV/Core EBITDA(x)8.496.066.175.486.65
   EV/EBIT(x)10.137.107.016.708.20
   EV/CE(x)0.740.690.690.420.52
   M Cap / Sales0.360.310.280.090.21
Growth Ratio
   Net Sales Growth(%)-0.9231.3328.1914.5529.63
   Core EBITDA Growth(%)-8.5612.8461.0211.0220.99
   EBIT Growth(%)-10.219.3373.5011.9823.78
   PAT Growth(%)-27.8227.06106.3265.5745.70
   EPS Growth(%)-27.8227.06106.3265.5745.70
Financial Stability Ratios
   Total Debt/Equity(x)1.070.781.251.361.21
   Current Ratio(x)1.181.291.341.191.22
   Quick Ratio(x)0.911.111.050.840.87
   Interest Cover(x)2.263.462.721.791.60
   Total Debt/Mcap(x)0.630.470.883.171.25

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.